#SpeakFoundation – Atamyo Therapeutics https://atamyo.com Changing life of Neuromuscular patients Tue, 10 Feb 2026 16:34:08 +0000 en-US hourly 1 https://wordpress.org/?v=6.7.5 https://atamyo.com/wp-content/uploads/cropped-favicon_atamyo-1-32x32.png #SpeakFoundation – Atamyo Therapeutics https://atamyo.com 32 32 Professor Isabelle Richard has received the Fifth Annual LGMD2i Pioneer Award from Cure LGMD2i Foundation and the Speak Foundation https://atamyo.com/non-classe/professor-isabelle-richard-has-received-the-fifth-annual-lgmd2i-pioneer-award-from-cure-lgmd2i-foundation-and-the-speak-foundation/ https://atamyo.com/non-classe/professor-isabelle-richard-has-received-the-fifth-annual-lgmd2i-pioneer-award-from-cure-lgmd2i-foundation-and-the-speak-foundation/#respond Thu, 12 Sep 2024 14:28:01 +0000 https://atamyo.com/?p=872
  • This award comes after an earlier award by the Jain Foundation for Leadership in Collaboration presented at the 2024 Dysferlin Conference

    • This recognition is for Isabelle Richard’s groundbreaking research on LGMD. Isabelle Richard, Ph.D., is Research Director at National Center of Scientific Research (CNRS) in France and head of the Progressive Muscular Dystrophies Laboratory at Genethon. We are proud to have Professor Richard as part of our team at Atamyo.

    Atamyo Therapeutics is grateful to the Speak Foundation and LGMD News Magazine for this wonderful article detailing the recent visit made by Kathryn Bryant Knudson, founder of the Speak Foundation to visit the labs and offices of Genethon and Atamyo in Evry, France. We express special thanks to Melanie Bordes, a patient advocate who leads AFMs LGMD Patient Interest Group. Read the article here

    ]]>     https://atamyo.com/non-classe/professor-isabelle-richard-has-received-the-fifth-annual-lgmd2i-pioneer-award-from-cure-lgmd2i-foundation-and-the-speak-foundation/feed/ 0